Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 3372 of 6351
-
Coffee-Inspired cream may protect breast cancer patients from radiation damage
Symptom relief OngoingThe purpose of the study is to evaluate whether a caffeine-based cream can reduce the rates of reconstructive complications in patients with tissue expander based reconstruction requiring post-mastectomy radiation therapy when compared to a placebo cream.
Phase 2 • Sponsor: NYU Langone Health • Aim: Symptom relief
Last updated Jun 27, 2026 13:02 UTC
-
New scaffold may help older patients heal torn shoulder tendons
Disease control CompletedRandomized controlled trial of patients over the age of 55 treated with and without a nanofiber scaffold during rotator cuff repair.
Sponsor: Atreon Orthopedics • Aim: Disease control
Last updated Jun 27, 2026 12:25 UTC
-
Can two drugs reboot radioiodine therapy for tough thyroid cancers?
Disease control CompletedThe purpose of this study is to develop a new drug treatment to reverse tumor resistance to radioiodine in BRAF mutant tumors so that radioiodine can be given to shrink tumors. This study is also being done to find out the highest doses of copanlisib and vemurafenib that, when gi…
Phase 1 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated Jun 26, 2026 14:34 UTC
-
New drug combo takes aim at Hard-to-Treat cancers
Disease control Recruiting nowPhase 1, open-label dose-escalation study to determine the MTD of INV-1120 and RP2D, and to assess the DLT of INV-1120 as a single agent or in the combination with pembrolizumab. The safety, tolerability, and PK of INV-1120 as a single agent or in the combination with pembrolizum…
Phase 1 • Sponsor: Shenzhen Ionova Life Sciences Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Experimental combo shows promise for tough bile duct cancer
Disease control Stopped earlyThe purpose of this research study is to determine the safety and efficacy of CPI-613 (devimistat) in the treatment of advanced biliary tract cancer when used in combination with standard of care chemotherapy (gemcitabine plus cisplatin) compared to gemcitabine plus cisplatin alo…
Phase 1/2 • Sponsor: University of Michigan Rogel Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
New registry tracks artificial sphincter success for female incontinence
Disease control CompletedProspective collection of pre-defined parameters of AUS Surgery for Female Stress Urinary Incontinence due to Intrinsic Sphincter Deficiency
Sponsor: European Association of Urology Research Foundation • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could a common heart drug tame nosebleeds in rare disease?
Symptom relief Stopped earlyHereditary Hemorrhagic Telangiectasia (HHT) is a genetic disorder of angiogenesis associated with disabling epistaxis. Management of these nose bleedings requires more effective treatment. Propranolol, a beta-blocker, is a potentially useful therapeutic considering its anti-angio…
Phase 3 • Sponsor: University Hospital, Bordeaux • Aim: Symptom relief
Last updated Jun 27, 2026 14:02 UTC
-
Why kidney disease drains your strength: scientists probe muscle fatigue
Knowledge-focused Stopped earlyChronic Kidney Disease (CKD) induces many metabolic troubles especially for the advanced CKD (stage 3b-5) patients and their prevalence and importance grow with the deterioration of the glomerular filtration rate (GFR). Among them, muscle wasting is common and multifactorial, par…
Sponsor: Centre Hospitalier le Mans • Aim: Knowledge-focused
Last updated Jul 03, 2026 00:00 UTC
-
Sound waves zapped brain to kill cancer pain – tiny study shows promise
Symptom relief CompletedThis proposed pilot study will investigate the safety and initial effectiveness of focused ultrasound lesioning of the contralateral mesencephalon for severe, opioid-resistant pain associated with head and neck cancer
Sponsor: Jeff Elias, MD • Aim: Symptom relief
Last updated Jun 27, 2026 07:55 UTC
-
Mini device implanted in prostate tumors could reveal best drug match
Knowledge-focused By invitation onlyIn this research study, is assessing the feasibility of using an MR-guided implantable microdevice to measure tumor response to chemotherapy and other clinically relevant drugs in participants that have prostate cancer and are scheduled for a radical prostatectomy. The name of t…
Phase 1 • Sponsor: Brigham and Women's Hospital • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:35 UTC
-
Could a tiny implant shield the rectum from radiation damage?
Disease control CompletedAssessment of efficacy and safety of implantable spacers when used to reduce the radiation dose delivered to the organs at risk in prostate cancer patients undergoing radiotherapy.
Sponsor: BioProtect • Aim: Disease control
Last updated Jun 26, 2026 17:55 UTC
-
Experimental cancer drug JSI-1187 tested in early trial
Disease control PausedThis is a Phase 1 study of JSI-1187 as monotherapy and in combination with dabrafenib for the treatment of advanced solid tumors with MAPK pathway mutations, including mutations that cause MAPK pathway hyperactivation.
Phase 1 • Sponsor: JS InnoPharm, LLC • Aim: Disease control
Last updated Jun 26, 2026 12:40 UTC
-
New MRI technique sharpens diagnosis of swollen optic nerve
Diagnosis CompletedThe presence of optic disc swelling at the fundus is a non-specific clinical sign that can occur in many ophthalmologic, neuro-ophthalmologic or encephalic pathologies. The diagnostic range is vast, including inflammatory pathologies of the optic nerve, infiltrative or compressiv…
Sponsor: Fondation Ophtalmologique Adolphe de Rothschild • Aim: Diagnosis
Last updated Jun 27, 2026 08:09 UTC
-
Phone coaching may ease fatigue after breast cancer
Symptom relief CompletedThe primary objective of MEDEA is to compare the effect of a personalised telephone-based health education weight loss program based on motivational coaching, exercise and diet versus a standard health educational program control on fatigue of overweight or obese BC patients (as …
Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Cash for clean breath: can remote monitoring help beat alcohol addiction?
Disease control OngoingDirectly reinforcing abstinence from alcohol with monetary incentives is an effective treatment for alcohol dependence, but barriers in obtaining frequent, verified biochemical measures of abstinence limit the dissemination of this treatment approach. The goal of this study is to…
Sponsor: Mikhail N Koffarnus • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
What happens to severe COVID-19 survivors after the ICU?
Knowledge-focused OngoingMany of the patients hospitalized for a severe form of SARSCoV-2 respiratory impairment require prolonged intensive care that can be complicated in the short term, In the medium and long term, physical and psychological sequelae can affect patients' quality of life and prevent a …
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:37 UTC
-
Can smarter monitoring of pancreatic cysts prevent cancer?
Knowledge-focused Recruiting nowThe purpose of this study is to compare two approaches for monitoring pancreatic cysts as well as to identify associated biomarkers. The study doctors want to compare more frequent monitoring versus less frequent monitoring as well as identify biomarkers which may improve risk de…
Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Knowledge-focused
Last updated Sep 06, 2026 00:00 UTC
-
Can therapy cut opioid use in chronic pain? new study explores how.
Knowledge-focused CompletedThis project will increase our understanding of the mechanisms underlying changes in opioid medication use associated with three psychosocial chronic pain (CP) treatments. These treatments are: (1) Cognitive Therapy (CT), (2) Mindfulness Meditation (MM), and (3) Behavioral Activa…
Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jun 27, 2026 14:02 UTC
-
Cancer drug ixazomib tested as potential MS treatment
Disease control Recruiting nowThe study seeks to investigate safety and efficacy of ixazomib (NINLARO), a proteasome inhibitor, in multiple sclerosis (MS). Participants will receive either ixazomib capsules or placebo capsules for up to 24 months.
Phase 1 • Sponsor: Queen Mary University of London • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC
-
Spinal fluid clues may unlock MS diagnosis and prognosis
Diagnosis CompletedTo determine if biomarker-based CSF testing is reliably detecting differences between patients with Multiple Sclerosis (MS), different MS-subtypes, and other central nervous system (CNS) diseases. This study will also look to identify biomarkers that could be used for the predict…
Sponsor: Washington University School of Medicine • Aim: Diagnosis
Last updated Jun 26, 2026 15:35 UTC